Literature DB >> 10048901

Primary subtype C HIV-1 infection in Harare, Zimbabwe.

P C Tien1, T Chiu, A Latif, S Ray, M Batra, C H Contag, L Zejena, M Mbizvo, E L Delwart, J I Mullins, D A Katzenstein.   

Abstract

Heterosexual transmission of HIV-1 is widespread in Southern Africa. Heteroduplex mobility assays (HMA) and phylogenetic analyses of V3-V5 envelope (env) gene sequences demonstrate that subtype C predominates in Zimbabwe. To elucidate factors contributing to the epidemic in Zimbabwe, clinical and virologic characteristics of recently acquired subtype C HIV-1 infection among 21 men and 1 woman were determined. In 12 of 19 men providing clinical histories, a sexually transmitted infection preceded serologic evidence of HIV-1, and 14 of 19 men complained of rash or fever before seroconversion. Quantitative p24 antigen levels, reverse transcriptase activity, and HIV RNA levels of 22 viral isolates correlated with in vitro infectivity in peripheral blood mononuclear cells (p < .05). Biologic phenotype assessed in MT-2 cells demonstrated that 3 of 22 isolates (14%) were syncytia inducing (SI) and the remaining 19 nonsyncytium inducing (NSI). Early growth of virus in culture was associated with increased plasma HIV RNA levels, decreased CD4 cell levels, and SI virus. Recent subtype C HIV-1 infection through heterosexual transmission in Zimbabwe demonstrated clinical and virologic features consistent with reports of seroconversion to subtype B viruses.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Body Temperature; Dermatitis; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Fever; Hiv; Hiv Infections; Immunity; Physiology; Research Report; Seroconversion; Signs And Symptoms; Viral Diseases; Zimbabwe

Mesh:

Substances:

Year:  1999        PMID: 10048901     DOI: 10.1097/00042560-199902010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  13 in total

1.  Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.

Authors:  Nina H Lin; Laura M Smeaton; Françoise Giguel; Vladimir Novitsky; Sikhulile Moyo; Rebecca M Mitchell; Joseph Makhema; Myron Essex; Shahin Lockman; Daniel R Kuritzkes
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

2.  Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.

Authors:  R Shankarappa; J B Margolick; S J Gange; A G Rodrigo; D Upchurch; H Farzadegan; P Gupta; C R Rinaldo; G H Learn; X He; X L Huang; J I Mullins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).

Authors:  R B Moss; W Giermakowska; M R Wallace; J Savary; F Jensen; D J Carlo
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

Authors:  L H Ping; J A Nelson; I F Hoffman; J Schock; S L Lamers; M Goodman; P Vernazza; P Kazembe; M Maida; D Zimba; M M Goodenow; J J Eron; S A Fiscus; M S Cohen; R Swanstrom
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe.

Authors:  L S Zijenah; J Humphrey; K Nathoo; L Malaba; P Zvandasara; A Mahomva; P Iliff; M T Mbizvo
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences.

Authors:  R Shankarappa; R Chatterjee; G H Learn; D Neogi; M Ding; P Roy; A Ghosh; L Kingsley; L Harrison; J I Mullins; P Gupta
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).

Authors:  Z Chen; Y Huang; X Zhao; E Skulsky; D Lin; J Ip; A Gettie; D D Ho
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

Authors:  Nina H Lin; Carlos Becerril; Francoise Giguel; Vladimir Novitsky; Sikhulile Moyo; Joseph Makhema; Myron Essex; Shahin Lockman; Daniel R Kuritzkes; Manish Sagar
Journal:  Virology       Date:  2012-09-03       Impact factor: 3.616

10.  Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

Authors:  Sarah C Ball; Awet Abraha; Kalonji R Collins; Andre J Marozsan; Heather Baird; Miguel E Quiñones-Mateu; Adam Penn-Nicholson; Michael Murray; Nathalie Richard; Michael Lobritz; Peter A Zimmerman; Tatsuyoshi Kawamura; Andrew Blauvelt; Eric J Arts
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.